Amino acid substitution at position 464 in the haemagglutinin-neuraminidase protein of a mumps virus Urabe strain enhanced the virus growth in neuroblastoma SH-SY5Y cells

Vaccine

Volumn 27, Issue 44, 2009, Pages 6160-6165

  Ninomiya, Kengo ^a   Kanayama, Tetsuya ^a   Fujieda, Nao ^a   Nakayama, Tetsuo ^b   Komase, Katsuhiro ^c   Nagata, Kyosuke ^a   Takeuchi, Kaoru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Mumps virus; Reverse genetics; SH SY5Y cells

Indexed keywords

ASPARAGINE; HN PROTEIN; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; MUMPS VIRUS; MUMPS VIRUS URABE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIROGENESIS; VIRUS GENE; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DNA, COMPLEMENTARY; GENES, VIRAL; GENOME, VIRAL; HN PROTEIN; HUMANS; MUMPS VIRUS; MUTAGENESIS, SITE-DIRECTED; RNA, VIRAL; VERO CELLS;

EID: 70349769157     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.020     Document Type: Article

References (30)

1. Carbone K.M., and Rubin S. Mumps virus. In: Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Strauss S.E. (Eds). Fields virology. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia 1527-1542
2. Bonnet M.C., Dutta A., Weinberger C., and Plotkin S.A. Mumps vaccine virus strains and aseptic meningitis. Vaccine 24 (2006) 7037-7045
3. Rubin S.A., Pletnikov M., and Carbone K.M. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J Virol 72 (1998) 8037-8042
4. Rubin S.A., Amexis G., Pletnikov M., Vanderzanden J., Mauldin J., Sauder C., et al. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 77 (2003) 11616-11624
5. Santos-Lopez G., Cruz C., Pazos N., Vallejo V., Reyes-Leyva J., and Tapia-Ramirez J. Two clones obtained from Urabe AM9 mumps virus vaccine differ in their replicative efficiency in neuroblastoma cells. Microbes Infect 8 (2006) 332-339
6. Rosas-Murrieta N., Herrera-Camacho I., Vallejo-Ruiz V., Millan-Perez-Pena L., Cruz C., Tapia-Ramirez J., et al. Differential sensitivity to interferon influences the replication and transcription of Urabe AM9 mumps virus variants in nerve cells. Microbes Infect 9 (2007) 864-872
7. Buchholz U.J., Finke S., and Conzelmann K.K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73 (1999) 251-259
8. Takeda M., Takeuchi K., Miyajima N., Kobune F., Ami Y., Nagata N., et al. Recovery of pathogenic measles virus from cloned cDNA. J Virol 74 (2000) 6643-6647
9. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
10. Kashiwagi Y., Takami T., Mori T., and Nakayama T. Sequence analysis of F, SH, and HN genes among mumps virus strains in Japan. Arch Virol 144 (1999) 593-599
11. Jin L., Rima B., Brown D., Orvell C., Tecle T., Afzal M., et al. Proposal for genetic characterization of wild-type mumps strains: Preliminary standardization of the nomenclature. Arch Virol 150 (2005) 1903-1909
12. Okazaki K., Tanabayashi K., Takeuchi K., Hishiyama M., Okazaki K., and Yamada A. Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology 188 (1992) 926-930
13. Amexis G., Fineschi N., and Chumakov K. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287 (2001) 234-241
14. Sasaki K., Higashihara M., Inoue K., Igarashi Y., and Makino S. Studies on the development of a live attenuated mumps virus vaccine. Kitasato Arch Exp Med 49 (1976) 43-52
15. Wright K.E., Dimock K., and Brown E.G. Biological characteristic of genetic variants of Urabe AM9 mumps vaccine virus. Virus Res 67 (2000) 49-57
16. Sauder C.J., Vandenburgh K.M., Iskow R.C., Malik T., Carbone K.M., and Rubin S.A. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350 (2006) 48-57
17. Malik T., Wolbert C., Mauldin J., Sauder C., Carbone K.M., and Rubin S.A. Functional consequences of attenuating mutations in the haemagglutinin-neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. J Gen Virol 88 (2007) 2533-2541
18. Kulkarni-Kale U., Ojha J., Manjari G.S., Deobagkar D.D., Mallya A.D., Dhere R.M., et al. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 359 (2007) 436-446
19. Brown E.G., Dimock K., and Wright K.E. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis 174 (1996) 619-622
20. Yetes P.J., Afzal M.A., and Minor P.D. Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 77 (1996) 2491-2497
21. Mori C., Tooriyama T., Imagawa T., and Yamanishi K. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. J Infect Dis 175 (1997) 1548
22. Brown E.G., and Wright K.E. Genetic studies on a mumps vaccine associated with meningitis. Rev Med Virol 8 (1998) 129-142
23. Afzal M.A., Yates P.J., and Minor P.D. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 177 (1998) 265-266
24. Cusi M.G., Santini L., Bianchi S., Valassina M., and Valensin P.E. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in wild-type strains of mumps virus is the most relevant marker of virulence. J Clin Microbiol 36 (1998) 3743-3744
25. Rubin S.A., Pletnikov M., Taffs R., Snoy P.J., Kobasa D., Brown E.G., et al. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 74 (2000) 5382-5384
26. Rubin S.A., Afzal M.A., Powell C.L., Bentley M.L., Auda G.R., Taffs R.E., et al. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J Infect Dis 191 (2005) 1123-1128
27. Clarke D.K., Sidhu M.S., Johnson J.E., and Udem S. Rescue of mumps virus from cDNA. J Virol 74 (2000) 4831-4838
28. Lemon K., Rima B.K., McQuaid S., Allen I.V., and Duprex W.P. The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol 81 (2007) 8293-8302
29. Malik T., Sauder C., Wolbert C., Zhang C., Carbone K.M., and Rubin S.A. Single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence. J Neurovirol 13 (2007) 513-521
30. Shah D., Vidal S., Link M.A., Rubin S.A., and Wright K.E. Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus. J Med Virol 81 (2009) 130-138